BioScale, Inc. Presents Data from a Novel Signal Transduction Pathway Analysis Using AMMP Assays at the 2012 American Association for Cancer Research Meeting

LEXINGTON, Mass.--(BUSINESS WIRE)--BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the activation state of the MAP kinase pathway at the 103rd Annual Meeting of the American Association for Cancer Research (AACR), held at McCormick Place in Chicago, Illinois, March 31 - April 4, 2012.